Cite
HARVARD Citation
Parmar, D. et al. (2022). Efficacy and safety of saroglitazar 4 mg compared to fenofibrate 160 mg in latino adults with moderate to severe hypertriglyceridemia-a randomized clinical trial. Atherosclerosis. pp. 257-. [Online].